A modelling study of a non-concerted hydrolytic cycloaddition reaction by the catalytic antibody H11
Clark, R.L. and Johnston, B.F. and Suckling, C.J. and Mackay, S.P. (2006) A modelling study of a non-concerted hydrolytic cycloaddition reaction by the catalytic antibody H11. Bioorganic and Medicinal Chemistry Letters, 14. pp. 2674-2683. ISSN 0960-894X (http://dx.doi.org/10.1016/j.bmc.2005.11.042)
Full text not available in this repository.Request a copyAbstract
H11 is the first antibody reported to have dual activity as a non-concerted, Diels-Alderase and hydrolytic catalyst. It was previously shown to catalyse the cycloaddition of acetoxybutadiene 1a to N-alkyl maleimides 2 to afford hydroxy-substituted bicyclic adducts 3 with a 30% ee of a major isomer. To better understand this mechanism and the partial stereospecificity, a homology model of H11 was constructed and used in docking studies to evaluate potential antibody-ligand complexes. The model suggested the hydrolytic nature of H11 was due to Glu 95H acting as a catalytic base, and evaluation of the shape complementarity of the proposed antibody-ligand complexes confirmed at a semi-quantitative level the observation that the major enantiomer is produced in a 30% ee.
ORCID iDs
Clark, R.L., Johnston, B.F. ORCID: https://orcid.org/0000-0001-9785-6822, Suckling, C.J. and Mackay, S.P. ORCID: https://orcid.org/0000-0001-8000-6557;-
-
Item type: Article ID code: 10624 Dates: DateEvent15 April 2006PublishedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Faculty of Science > Pure and Applied ChemistryDepositing user: Strathprints Administrator Date deposited: 01 Oct 2010 18:32 Last modified: 11 Nov 2024 08:59 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/10624